New York University (NYU)

University / College


Location: New York, NY, United States (USA) (US) US

ISNI: 0000000419368753

ROR: https://ror.org/0190ak572

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Vector Approximate Message Passing for 3D MIMO Radar (2024) Eisele B, Bereyhi A, Müller R, Rangan S Conference contribution, Conference Contribution From Text to Treatment: How Medical Discharge Letters Are Used as a Key Artifact for Managing Patient Care (2024) Zakreuskaya A, Buschek D, Mackay WE, Avellino I, Dove G, Eskofier B Conference contribution Recognizing and Managing Allergic Contact Dermatitis: Focus on Major Allergens (2024) Fonacier L, Uter W, Johansen JD Journal article Bridging Gaps with Generative AI: Enhancing Hypertension Monitoring Through Patient and Provider Insights (2024) Andreadis K, Rodriguez DV, Zakreuskaya A, Chen J, Gonzalez J, Mann D Conference contribution Imaging Biomarkers of Osteoarthritis (2024) Roemer FW, Wirth W, Demehri S, Kijowski R, Jarraya M, Hayashi D, Eckstein F, Guermazi A Journal article Further delineation of the SCAF4-associated neurodevelopmental disorder (2024) Schmid CM, Gregor A, Ruiz A, Manso Bazús C, Herman I, Ammouri F, Kotzaeridou U, et al. Journal article Ferroptosis in health and disease. (2024) Berndt C, Alborzinia H, Amen VS, Ayton S, Barayeu U, Bartelt A, Bayir H, et al. Journal article, Review article Big data research is everyone's research—Making epilepsy data science accessible to the global community: Report of the ILAE big data commission (2024) Josephson CB, Aronica E, Beniczky S, Boyce D, Cavalleri G, Denaxas S, French J, et al. Journal article, Review article A phase 2 open-label study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (EMPOWER-CSCC-1): Final long-term analysis of groups 1, 2, and 3, and primary analysis of fixed-dose treatment group 6 (2024) Hughes BG, Guminski A, Bowyer S, Migden MR, Schmults CD, Khushalani NI, Chang ALS, et al. Journal article Hybrid zinc oxide nanocoating on titanium implants: Controlled drug release for enhanced antibacterial and osteogenic performance in infectious conditions (2024) Zhou J, Wang H, Virtanen S, Witek L, Dong H, Thanassi D, Shen J, et al. Journal article